| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |